Au KH, Ngan RKC, Ng AWY, Poon DMC, Ng WT, Yuen KT, Lee VHF, Tung SY, Chan ATC, Sze HCK, Cheng ACK, Lee AWM, Kwong DLW, Tam AHP (2018) Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: a report of 3328 patients (HKNPCSG 1301 study). Oral on 77:16–21. https://doi.org/10.1016/j.oraloncology.2017.12.004

Article  CAS  Google Scholar 

Cao SM, Yang Q, Guo L, Mai HQ, Mo HY, Cao KJ, Qian CN, Zhao C, Xiang YQ, Zhang XP, Lin ZX, Li WX, Liu Q, Qiu F, Sun R, Chen QY, Huang PY, Luo DH, Hua YJ, Wu YS, Lv X, Wang L, Xia WX, Tang LQ, Ye YF, Chen MY, Guo X, Hong MH (2017) Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase III multicentre randomised controlled trial. Eur J Cancer 75:14–23. https://doi.org/10.1016/j.ejca.2016.12.039

Article  CAS  PubMed  Google Scholar 

Chang H, Peng L, Tao YL, Chen C, Xiao WW, Hu YH, Gao YH (2019) Necessity of concurrent chemotherapy in N2–3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity-modulated radiotherapy. Cancer Med 8(6):2823–2831. https://doi.org/10.1002/cam4.2179

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen YP, Tang LL, Yang Q, Poh SS, Hui EP, Chan ATC, Ong WS, Tan T, Wee J, Li WF, Chen L, Ma BBY, Tong M, Tan SH, Cheah SL, Fong KW, Sommat K, Soong YL, Guo Y, Lin AH, Sun Y, Hong MH, Cao SM, Chen MY, Ma J (2018) Induction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trials. Clin Cancer Res 24(8):1824–1833. https://doi.org/10.1158/1078-0432.Ccr-17-2656

Article  CAS  PubMed  Google Scholar 

Chen R, Lu Y, Zhang Y, He R, Tang F, Yuan W, Li Y, Zhang X (2021) Comparison of therapeutic efficacy and toxicity of docetaxel, cisplatin, and fluorouracil (TPF)-based induction chemotherapy plus concurrent chemoradiotherapy and chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma. Medicine (Baltimore) 100(42):e27475. https://doi.org/10.1097/md.0000000000027475

Article  CAS  PubMed  Google Scholar 

Chow JCH, Tam AHP, Cheung KM, Lee VHF, Chiang CL, Tong M, Wong ECY, Cheung AKW, Chan SPC, Lai JWY, Ngan RKC, Ng WT, Lee AWM, Au KH (2020) Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: a territory-wide study by HKNPCSG. Oral Oncol 111:105012. https://doi.org/10.1016/j.oraloncology.2020.105012

Article  PubMed  Google Scholar 

De Felice F, Musio D, Tombolini V (2016) Osteoradionecrosis and intensity modulated radiation therapy: an overview. Crit Rev Oncol Hematol 107:39–43. https://doi.org/10.1016/j.critrevonc.2016.08.017

Article  PubMed  Google Scholar 

De Felice F, Cirillo A, Botticelli A (2022) Ideal regimen for induction chemotherapy in nasopharyngeal cancer: still a hot issue? Radiother Oncol 177:111–112. https://doi.org/10.1016/j.radonc.2022.10.033

Article  PubMed  Google Scholar 

Du C, Ying H, Zhou J, Hu C, Zhang Y (2013) Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma. Int J Clin Oncol 18(3):464–471. https://doi.org/10.1007/s10147-012-0403-y

Article  CAS  PubMed  Google Scholar 

Fangzheng W, Chuner J, Quanquan S, Zhimin Y, Tongxin L, Jiping L, Sakamoto M, Peng W, Kaiyuan S, Weifeng Q, Zhenfu F, Yangming J (2017a) Addition of 5-fluorouracil to docetaxel/cisplatin does not improve survival in locoregionally advanced nasopharyngeal carcinoma. Oncotarget 8(70):115469–115479. https://doi.org/10.18632/oncotarget.23300

Article  PubMed  PubMed Central  Google Scholar 

Fangzheng W, Quanquan S, Chuner J, Lei W, Fengqin Y, Zhimin Y, Tongxin L, Min X, Peng W, Haitao J, Aizawa R, Sakamoto M, Yuezhen W, Zhenfu F (2017b) Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma. Oncotarget 8(57):96798–96808. https://doi.org/10.18632/oncotarget.18245

Article  PubMed  PubMed Central  Google Scholar 

Huang J, Yang ZY, Wu B, Ding Q, Qin Y, Zhang ZJ, Yin ZY, Liang ZW, Han J, Wang Y, Peng ZJ, Peng G, Li Q, Wu G, Yang KY (2021) Long-term therapeutic outcome and prognostic factors of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: an analysis of 608 patients from low-endemic regions of China. Curr Med Sci 41(4):737–745. https://doi.org/10.1007/s11596-021-2405-3

Article  CAS  PubMed  Google Scholar 

Hui EP, Ma BB, Leung SF, King AD, Mo F, Kam MK, Yu BK, Chiu SK, Kwan WH, Ho R, Chan I, Ahuja AT, Zee BC, Chan AT (2009) Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol 27(2):242–249. https://doi.org/10.1200/jco.2008.18.1545

Article  CAS  PubMed  Google Scholar 

Jamshed A, Hussain R, Iqbal H (2014) Gemcitabine and cisplatin followed by chemo-radiation for advanced nasopharyngeal carcinoma. Asian Pac J Cancer Prev 15(2):899–904. https://doi.org/10.7314/apjcp.2014.15.2.899

Article  PubMed  Google Scholar 

Jiang F, Jin T, Feng XL, Jin QF, Chen XZ (2015) Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: the Zhejiang cancer hospital’s experience. J Cancer Res Ther 11(Suppl 2):C179-184. https://doi.org/10.4103/0973-1482.168181

Article  CAS  PubMed  Google Scholar 

Jin T, Qin WF, Jiang F, Jin QF, Wei QC, Jia YS, Sun XN, Li WF, Chen XZ (2019) Cisplatin and fluorouracil induction chemotherapy with or without docetaxel in locoregionally advanced nasopharyngeal carcinoma. Transl Oncol 12(4):633–639. https://doi.org/10.1016/j.tranon.2019.01.002

Article  PubMed  PubMed Central  Google Scholar 

Koch A, Reinhardt P, Elicin O, Aebersold DM, Schanne DH (2025) Predictive biomarkers of radiotherapy- related dermatitis, xerostomia, mucositis and dysphagia in head and neck cancer: a systematic review. Radiother Oncol 203:110689. https://doi.org/10.1016/j.radonc.2024.110689

Article  CAS  PubMed  Google Scholar 

Kong M, Lim YJ, Kim Y (2018) Concurrent chemoradiotherapy for loco-regionally advanced nasopharyngeal carcinoma: treatment outcomes and prognostic factors. Asian Pac J Cancer Prev 19(6):1591–1599. https://doi.org/10.22034/apjcp.2018.19.6.1591

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kong FF, Ni MS, Zhai RP, Ying HM, Hu CS (2022) Local control and failure patterns after intensity modulated radiotherapy with reduced target volume delineation after induction chemotherapy for patients with T4 nasopharyngeal carcinoma. Transl Oncol 16:101324. https://doi.org/10.1016/j.tranon.2021.101324

Article  PubMed  Google Scholar 

Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu LZ, Sun Y, Lin AH, Liu MZ, Ma J (2011) How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys 80(3):661–668. https://doi.org/10.1016/j.ijrobp.2010.03.024

Article  PubMed  Google Scholar 

Li WF, Chen NY, Zhang N, Hu GQ, Xie FY, Sun Y, Chen XZ, Li JG, Zhu XD, Hu CS, Xu XY, Chen YY, Hu WH, Guo L, Mo HY, Chen L, Mao YP, Sun R, Ai P, Liang SB, Long GX, Zheng BM, Feng XL, Gong XC, Li L, Shen CY, Xu JY, Guo Y, Chen YM, Zhang F, Lin L, Tang LL, Liu MZ, Ma J, Sun Y (2019) Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: long-term results of phase 3 randomized controlled trial. Int J Cancer 145(1):295–305. https://doi.org/10.1002/ijc.32099

Article  CAS  PubMed  Google Scholar 

Liu SL, Sun XS, Xie HJ, Chen QY, Lin HX, Liang H, Liang YJ, Li XY, Yan JJ, Lin C, Yang ZC, Guo SS, Liu LT, Tang QN, Du YY, Tang LQ, Guo L, Mai HQ (2020) Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level. BMC Cancer 20(1):89. https://doi.org/10.1186/s12885-020-6555-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nazeer F, Poulose JV, Kainickal CT (2022) Induction chemotherapy in nasopharyngeal carcinoma- a systematic review of phase III clinical trials. Cancer Treat Res Commun 32:100589. https://doi.org/10.1016/j.ctarc.2022.100589

Article  PubMed  Google Scholar 

NCCN Clinical Practice Guidelines in Oncology (NCCN): head and neck cancers. Version 3.2024.

Ou X, Zhou X, Shi Q, Xing X, Yang Y, Xu T, Shen C, Wang X, He X, Kong L, Ying H, Hu C (2015) Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost. Oncotarget 6(35):38381–38397. https://doi.org/10.18632/oncotarget.5420

Article  PubMed  PubMed Central  Google Scholar 

Peng G, Wang T, Yang KY, Zhang S, Zhang T, Li Q, Han J, Wu G (2012) A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol 104(3):286–293. https://doi.org/10.1016/j.radonc.2012.08.013

Article  PubMed